Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
about
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virusHepatitis B virus infection. Current concepts of chronicity and immunity.Update on diagnosis, management, and prevention of hepatitis B virus infection.Immunogenicity of peptide fusions to hepatitis B virus core antigen.Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopesNew hepatitis B vaccines.Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.Hepatitis B vaccinationMarkedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant.Successful immunization with a totally synthetic diphtheria vaccineImmunological castration of male mice by a totally synthetic vaccine administered in saline.Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigenInhibition of a common human anti-hepatitis B surface antigen idiotype by a cyclic synthetic peptide.Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequencesA synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees.Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin.Biochemical and immunological characterization of the duck hepatitis B virus envelope proteins.Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus.Antibody responses to recombinant and plasma derived hepatitis B vaccines.Folding and stability of sweet protein single-chain monellin. An insight to protein engineering.Increasing heterogeneity of the 'a' determinant of HBsAg found in the presumed late phase of chronic hepatitis B virus infection.Mise au point de nouveaux vaccins anti-h?patite B.L'hépatite virale.Hepatitis B envelope protein mutants in human hepatocellular carcinoma tissues.Towards new vaccines.Viral hepatitis
P2860
Q27485919-98C3ED01-CDF8-4D44-AC14-A52CB26531F2Q33581104-885CA17F-E48F-4012-A3E5-C88E91A63231Q33588921-1FD0747E-0254-4E4A-8B2A-4CE280771173Q34297568-9F9224A5-9EDC-4EC0-89B3-68C54C305F36Q34321397-23055986-7E5E-4FB5-A09E-0F8A931D8882Q34490083-E401D42F-40DE-457E-B36D-EEDE122B25AEQ35679043-0605403A-D31C-422F-B556-144AA0190B65Q35886996-25679141-C8B5-4447-AA95-96ED17C3C628Q36213588-260CB7D2-21D3-4019-92D2-40EF0A19671CQ36264118-C49C481A-615A-4CF7-82E8-BEE119C8433EQ36304771-B7C97229-AF9A-4752-B792-1130A971095EQ36308543-449DD66C-4678-4292-AD84-DAE8C9D174A3Q36311031-EEE7C529-8C7D-4E8A-B445-8D2FC3D4EDE2Q36327658-9E010A82-1E62-4F2A-956B-2BAC62296B07Q36906492-9CA33DAD-AED7-43C6-B549-DF55BF6A5220Q36913034-3961E76C-4994-4D81-B3D7-37D72DCC7B23Q37410079-D2775F9B-6396-4FBB-8EE0-492B7A5BBDD1Q37609547-9DEACCD2-868C-419B-AE68-20ED6C54A7A6Q37690884-6952F1DD-29B4-4EBA-9CFA-483D6E6CB452Q40281152-741D3178-9B55-4935-9617-7A497A0F698BQ41308046-EAACFF92-A2A8-44AF-8CF5-AA9251685A76Q42088091-D14B93B8-2ADF-46B7-9841-CD7086510AFFQ43715883-EB2FDB83-85EA-477B-A4FC-C5FD59BFA046Q45763604-AC40B1A9-A8B0-4939-8075-53650E1E472CQ45797700-6782E2D3-B4B3-4A11-BA81-5FFF50D568B7Q46165335-2E733EDE-FBDD-494C-88E3-0555E60D805EQ54254971-A2BFA6FD-5860-4BF8-880B-F682A9D8BD7BQ55137546-D8E56B5B-8257-44D6-9D0A-51E949C86CD5Q57007210-84329A5E-6746-4BD0-A686-9BD61E19BB60
P2860
Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@ast
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@en
type
label
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@ast
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@en
prefLabel
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@ast
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@en
P2093
P2860
P356
P1476
Hepatitis B virus vaccine: ide ...... synthetic immunogenic peptide.
@en
P2093
P2860
P304
P356
10.1073/PNAS.79.2.579
P407
P577
1982-01-01T00:00:00Z